Comparison of survival outcomes among standard radiotherapy regimens in limited-stage small cell lung cancer patients receiving concurrent chemoradiation
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The optimal radiotherapy dose in concurrent chemoradiation (CRT) for limited-stage
small cell lung cancer (SCLC) is controversial. We compared the effectiveness of several
high-dose chemoradiation regimens using a large national dataset.